Little Difference in eGFR With or Without Cotherapy with Methotrexate in Gout Treated with Pegloticase

An analysis of eGFR changes based on methotrexate use in the MIRROR trial offers new insight into the effects of pegloticase on renal function.

Related Keywords

United States ,Alaska ,American ,John Botson ,National Kidney Foundation ,Drug Administration ,Orthopedic Physicians Alaska ,Clinical Meeting ,Pegloticase Injection ,Horizon Therapeutics ,